The global Radiofrequency Ablation Devices market garnered revenue around USD 544.1 Million in 2019 and projected to reach USD 1.5 Billion in 2027, with at a compound annual growth rate (CAGR) 11.1% throughout the estimate period from 2020 to 2027.
Radiofrequency ablation is a minimally invasive surgical procedure that involves a local anesthetic and mild sedation. This procedure is primarily used to reduce chronic low-back and neck pain. The procedure involves heating a small area of nervous tissue under controlled temperature and as a result help in blockage of pain signals transmitting from that area.
North America dominated the global radiofrequency ablation devices for pain management market in 2019 and the trend is anticipated to continue during the forecast period. Rise in awareness regarding the treatment benefits, high incidence rate of chronic pain among the population in the U.S. are expected to drive the market in North America.
However, Asia Pacific is likely to be a highly lucrative market for radiofrequency ablation devices for pain management and it is expected to expand at a high CAGR during the forecast period
This research report encompasses precise assessment of the market with the help of comprehensive qualitative insights and supportable prognoses regarding market size, consumption and production. The projections presented in the report have been derived using proven research methodologies and assumptions. It does so by means of comprehensive qualitative insights, historical statistics, and verifiable predictions about market revenue and sales.
The rapidly budding threat owed to the eruption of COVID-19 is impacting lives, communities, businesses, and industries across the globe. With businesses shuttered, flights grounded, COVID-19 is about to affect the global economy in different ways such as by directly upsetting production and demand, by generating supply chain disruption, and by its financial impact on firms and financial markets. Therefore, this report covers COVID-19 outbreak impact analysis on the Radiofrequency Ablation Devices market under the research study. The market estimates offered in the report are the outcome of in-depth extensive secondary research, primary interviews and in-house professional assessments. These market evaluations have been measured by reviewing the impact of numerous social, political and economic factors coupled with recent market dynamics affecting the Radiofrequency Ablation Devices market growth.
The global Radiofrequency Ablation Devices market is characterized by the presence of numerous small as well as medium scale companies. These players are largely focused towards forward integration via raw material production, product manufacturing, and distribution across various industry verticals. The report recognizes numerous crucial manufacturers of the market. This research study aids to comprehend the strategies and associations that companies are converging to survive in this competitive marketplace. This report assists in understanding footprints of the manufacturers with the help of their global revenue, production, capacity and average selling price analysis for period 2016-2027.
Major manufacturers analysed under this study comprises:
the global market include Boston Scientific Corporation, Diros Technology, Inc., Halyard Health, Inc., Abbott, Stryker Corporation, Olympus Corporation, Merit Medical Systems, Medtronic plc, and AngioDynamic, Inc.
This report delivers market breakdown and its revenue, consumption, production analysis and projections by categorizing it depending on parameters such as type, application/end-user, and region. This research report delivers the analysis and prognosis of revenue, production, price, market share and growth trend for different products such as:
Regional Analysis and Forecast
Further, this research study analyses market size, production, consumption and its advancement trends at global, regional, and country level for period 2016 to 2027 and covers following region in its scope: